Radiation 'Warhead' trial aims to give tough leukemia patients a fighting chance
NCT ID NCT07157514
Summary
This study is testing a new treatment approach for adults with acute myeloid leukemia (AML) that has returned or not responded to standard therapies. It combines a targeted radiation drug with chemotherapy and low-dose whole-body radiation to prepare patients for a stem cell transplant from a donor. The main goal is to see if this new combination helps people live longer compared to the current standard treatment before transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA, IN RELAPSE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.